Table 3.
Patient characteristics | Total | Primary care | Specialized care | P value | |||
|
|
|
DEa (n=83) | PLb (n=34) | NLc (n=44) | FRd (n=39) |
|
Gender (female), n (%) | 129 (64.5) | 51 (61.4) | 25 (73.5) | 27 (61.4) | 26 (66.7) | .61 | |
Age (years), mean (SD) | 41.7 (12.9) | 43.2 (13.1) | 36.4 (13.1) | 39.4 (9.8) | 45.9 (13.6) | .005 | |
Education level, n (%) | |||||||
|
Low | 24 (12.0) | 15 (18.1) | 2 (5.9) | 6 (13.6) | 1 (2.6) | .004 |
Middle | 74 (37.0) | 21 (25.3) | 11 (32.4) | 24 (54.5) | 18 (46.2) | .004 | |
High | 102 (51.0) | 47 (56.6) | 21 (61.8) | 14 (31.8) | 20 (51.3) | .004 | |
In a relationship, n (%) | 117 (58.5) | 51 (61.4) | 24 (70.6) | 24 (54.5) | 18 (46.2) | .17 | |
Baseline PHQe, mean (SD) | 16.2 (4.7) | 15.5 (4.1) | 16.3 (5.0) | 16.9 (5.8) | 16.8 (4.6) | .33 | |
Comorbidity, n (%)f | 113 (60.1) | 34 (41.5) | 17 (50.0.9) | 34 (77.3) | 28 (71.8) | <.001 | |
Treatment preference, n (%) | |||||||
|
Blended | 117 (58.5) | 64 (77.1) | 24 (70.6) | 21 (47.7) | 8 (20.5) | <.001 |
TAUg | 29 (14.5) | 6 (7.2) | 1 (3.3) | 7 (15.9) | 15 (38.5) | <.001 | |
Nonh | 54 (27.0) | 13 (15.7) | 9 (26.5) | 16 (36.4) | 16 (41.0) | <.001 |
aDE: Germany.
bPL: Poland.
cNL: the Netherlands.
dFR: France.
ePHQ: Patient Health Questionnaire-9.
f≥1 comorbid disorder, as assessed with the Mini International Neuropsychiatric Interview.
gTAU: treatment-as-usual.
hNon: no treatment preference.